Dexcom DXCM
NASDAQ DXCM
$90.54 +0.67 (+0.74%)
At close: Aug 20, 2026 · 11:15 AM UTC

Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) posted quarterly Other Non-Current Liabilities of $150.8 million for Q2 2026, down 0.53% year-over-year from $151.6 million in Q2 2025, and up 6.35% quarter-over-quarter from $141.8 million in Q1 2026.

Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Dexcom (DXCM) has reported Other Non-Current Liabilities for 17 consecutive years, with $150.8 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities fell 0.53% year-over-year to $150.8 million; the TTM figure through Jun 2026 stood at $150.8 million (down 0.53% YoY), while the FY2025 annual figure was $137.1 million, down 7.3% from the prior year.
  • Other Non-Current Liabilities rose to $150.8 million in Q2 2026 per DXCM's latest filing, from $141.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $151.6 million in Q2 2025 and bottomed at $97.1 million in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $132.5 million across 5 years, with a median of $131.4 million in 2023.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 42.56% — and 2025, when it fell 7.3%.
  • Dexcom's Other Non-Current Liabilities stood at $128.3 million in 2022, then decreased by 2.1% to $125.6 million in 2023, then advanced by 17.75% to $147.9 million in 2024, then slipped by 7.3% to $137.1 million in 2025, then advanced by 9.99% to $150.8 million in 2026.
  • Business Quant data shows DXCM's Other Non-Current Liabilities at $150.8 million in Q2 2026, $141.8 million in Q1 2026, and $137.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 150.80 Mn
Mar 31, 2026 141.80 Mn
Dec 31, 2025 137.10 Mn
Sep 30, 2025 147.40 Mn
Jun 30, 2025 151.60 Mn
Mar 31, 2025 150.30 Mn
Dec 31, 2024 147.90 Mn
Sep 30, 2024 129.60 Mn
Jun 30, 2024 128.10 Mn
Mar 31, 2024 129.40 Mn
Dec 31, 2023 125.60 Mn
Sep 30, 2023 133.90 Mn
Jun 30, 2023 133.10 Mn
Mar 31, 2023 129.70 Mn
Dec 31, 2022 128.30 Mn
Sep 30, 2022 123.30 Mn
Jun 30, 2022 99.50 Mn
Mar 31, 2022 97.10 Mn
Dec 31, 2021 90.00 Mn
Sep 30, 2021 98.50 Mn